Nasdaq Confirms No Adjustment for OSR Health CVR
Analysis based on 12 articles · First reported Jul 31, 2026 · Last updated Jul 31, 2026
The clarification removes a potential overhang on OSR Health's stock, as investors no longer fear a mechanical downward adjustment. The stock traded down 2.05% on the day, but the news provides regulatory clarity that may support investor confidence in the loyalty program.
On July 31, 2026, OSR Health, Inc. announced that the Nasdaq Stock Market verbally confirmed that its Shareholder Loyalty Contingent Value Rights (CVR) program will not trigger any mechanical price adjustment to OSR Health's common stock, either upon the distribution of the CVRs or upon the delivery of additional shares to enrolled holders. This clarification removes a structural uncertainty for shareholders, ensuring that the stock price will be determined purely by market forces. The record date for enrollment is August 14, 2026, and enrolled shareholders who hold their shares continuously may receive additional shares at no cost if defined closing-price thresholds are met over four measurement dates in the following twelve months. CEO Peter Hwang and Head of Investor Relations Tim Smith emphasized the program's additive nature and the company's focus on simplifying enrollment. OSR Health is a global healthcare holding company engaged in immuno-oncology, regenerative biologics, and medical device technologies.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard